These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 19013497)
1. DHEA metabolism in prostate: For better or worse? Arnold JT Mol Cell Endocrinol; 2009 Mar; 301(1-2):83-8. PubMed ID: 19013497 [TBL] [Abstract][Full Text] [Related]
2. TGFβ1 alters androgenic metabolites and hydroxysteroid dehydrogenase enzyme expression in human prostate reactive stromal primary cells: Is steroid metabolism altered by prostate reactive stromal microenvironment? Piao YS; Wiesenfeld P; Sprando R; Arnold JT J Steroid Biochem Mol Biol; 2013 Nov; 138():206-13. PubMed ID: 23770322 [TBL] [Abstract][Full Text] [Related]
3. Human prostate stromal cells stimulate increased PSA production in DHEA-treated prostate cancer epithelial cells. Arnold JT; Gray NE; Jacobowitz K; Viswanathan L; Cheung PW; McFann KK; Le H; Blackman MR J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):240-6. PubMed ID: 18621129 [TBL] [Abstract][Full Text] [Related]
4. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Arnold JT; Le H; McFann KK; Blackman MR Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203 [TBL] [Abstract][Full Text] [Related]
5. Endocrine-immune-paracrine interactions in prostate cells as targeted by phytomedicines. Gray NE; Liu X; Choi R; Blackman MR; Arnold JT Cancer Prev Res (Phila); 2009 Feb; 2(2):134-42. PubMed ID: 19141600 [TBL] [Abstract][Full Text] [Related]
6. Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone. Mizokami A; Koh E; Izumi K; Narimoto K; Takeda M; Honma S; Dai J; Keller ET; Namiki M Endocr Relat Cancer; 2009 Dec; 16(4):1139-55. PubMed ID: 19608712 [TBL] [Abstract][Full Text] [Related]
7. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells. Le H; Arnold JT; McFann KK; Blackman MR Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782 [TBL] [Abstract][Full Text] [Related]
8. Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue. Poortman J; Prenen JA; Schwarz F; Thijssen JH J Clin Endocrinol Metab; 1975 Mar; 40(3):373-9. PubMed ID: 163841 [TBL] [Abstract][Full Text] [Related]
9. SEMA3C induces androgen synthesis in prostatic stromal cells through paracrine signaling. Yenki P; Adomat HH; Ong CJ Prostate; 2021 May; 81(6):309-317. PubMed ID: 33503318 [TBL] [Abstract][Full Text] [Related]
10. The EPI bioassay identifies natural compounds with estrogenic activity that are potent inhibitors of androgenic pathways in human prostate stromal and epithelial cells. Vollmer G; Helle J; Amri H; Liu X; Arnold JT J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):153-62. PubMed ID: 22207083 [TBL] [Abstract][Full Text] [Related]
11. Comparative effects of DHEA and DHT on gene expression in human LNCaP prostate cancer cells. Steele VE; Arnold JT; Lei H; Izmirlian G; Blackman MR Anticancer Res; 2006; 26(5A):3205-15. PubMed ID: 17094431 [TBL] [Abstract][Full Text] [Related]
12. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. Labrie F; Bélanger A; Cusan L; Candas B J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308 [TBL] [Abstract][Full Text] [Related]
13. Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues. Arai S; Miyashiro Y; Shibata Y; Tomaru Y; Kobayashi M; Honma S; Suzuki K Steroids; 2011 Feb; 76(3):301-8. PubMed ID: 21147140 [TBL] [Abstract][Full Text] [Related]
14. CYP7B generates a selective estrogen receptor beta agonist in human prostate. Martin C; Ross M; Chapman KE; Andrew R; Bollina P; Seckl JR; Habib FK J Clin Endocrinol Metab; 2004 Jun; 89(6):2928-35. PubMed ID: 15181079 [TBL] [Abstract][Full Text] [Related]
15. Dehydroepiandrosterone (DHEA) is an anabolic steroid like dihydrotestosterone (DHT), the most potent natural androgen, and tetrahydrogestrinone (THG). Labrie F; Luu-The V; Martel C; Chernomoretz A; Calvo E; Morissette J; Labrie C J Steroid Biochem Mol Biol; 2006 Jul; 100(1-3):52-8. PubMed ID: 16797178 [TBL] [Abstract][Full Text] [Related]
16. The synergistic effect of sustained delivery of DHT, DHEA, and E on the ventral prostate of adult male rodents. Cavett W; Cason Z; Tucci M; Puckett A; Benghuzzi H Biomed Sci Instrum; 1997; 34():30-5. PubMed ID: 9603008 [TBL] [Abstract][Full Text] [Related]
17. Dihydrotestosterone inhibits arylsulfatase B and Dickkopf Wnt signaling pathway inhibitor (DKK)-3 leading to enhanced Wnt signaling in prostate epithelium in response to stromal Wnt3A. Bhattacharyya S; Feferman L; Tobacman JK Prostate; 2019 May; 79(7):689-700. PubMed ID: 30801800 [TBL] [Abstract][Full Text] [Related]
18. Is dehydroepiandrosterone a hormone? Labrie F; Luu-The V; Bélanger A; Lin SX; Simard J; Pelletier G; Labrie C J Endocrinol; 2005 Nov; 187(2):169-96. PubMed ID: 16293766 [TBL] [Abstract][Full Text] [Related]
19. Dehydroepiandrosterone-induced proliferation of prostatic epithelial cell is mediated by NFKB via PI3K/AKT signaling pathway. Sun HZ; Yang TW; Zang WJ; Wu SF J Endocrinol; 2010 Mar; 204(3):311-8. PubMed ID: 20007738 [TBL] [Abstract][Full Text] [Related]
20. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Labrie F; Luu-The V; Labrie C; Bélanger A; Simard J; Lin SX; Pelletier G Endocr Rev; 2003 Apr; 24(2):152-82. PubMed ID: 12700178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]